All I know is I want a couple EUA’s or BTD’s before anybody even considers a partnership with big Pharma. Then I want someone to try to convince me that is the right path to have a partnership. Splitting profits just don’t sound like a good deal to a greedy me…

I don’t even want a a buy out at any point and lose the potential of company like CytoDyn represents. Please tell me why a buy out is a good plan at any time when Leronlimab can be a multi approved drug and be a platform drug. Why… why would someone believe a buy out is even a good idea and please explain this to me.

For me it is all about good things come to those that wait. Waiting is ok for most but not all and at any time after our ascending pattern starts… people can sell and pull out their profits and or sell everything.

I just wanted to also touch on the premise that future expenses might need to be addressed in allowing more shares at this years shareholders meeting. I would love to believe that massive revenue will be available before we have any further dilution but reality is we can not bet the farm on such a premise. We have to know that it will be on our shareholder voting agenda this year. This is just being realistic and heaven knows I don’t want dilution to happen but longevity is by far the better option. I am hoping like everyone that approvals are sooner than later and life will be good very soon. It’s what we all want to believe!